{
  "id": 11409,
  "date": "2019-07-03T12:45:08",
  "date_gmt": "2019-07-03T12:45:08",
  "guid": { "rendered": "./?p=11409" },
  "modified": "2019-07-03T12:45:08",
  "modified_gmt": "2019-07-03T12:45:08",
  "slug": "regulatory-times-may-2019",
  "status": "publish",
  "type": "post",
  "link": "./blog/regulatory-times-may-2019/",
  "title": { "rendered": "The Regulatory Times &#8211; May 2019" },
  "content": {
    "rendered": "<p><div class=\"fusion-fullwidth fullwidth-box fusion-builder-row-1 nonhundred-percent-fullwidth non-hundred-percent-height-scrolling\" style=\"background-color: rgba(255,255,255,0);background-position: center center;background-repeat: no-repeat;padding-top:0px;padding-right:0px;padding-bottom:0px;padding-left:0px;margin-bottom: 0px;margin-top: 0px;border-width: 0px 0px 0px 0px;border-color:#eae9e9;border-style:solid;\" ><div class=\"fusion-builder-row fusion-row\"><div class=\"fusion-layout-column fusion_builder_column fusion-builder-column-0 fusion_builder_column_1_1 1_1 fusion-one-full fusion-column-first fusion-column-last\" style=\"margin-top:0px;margin-bottom:0px;\"><div class=\"fusion-column-wrapper fusion-flex-column-wrapper-legacy\" style=\"background-position:left top;background-repeat:no-repeat;-webkit-background-size:cover;-moz-background-size:cover;-o-background-size:cover;background-size:cover;padding: 0px 0px 0px 0px;\"><ul class=\"fusion-checklist fusion-checklist-1\" style=\"font-size:13px;line-height:22.1px;\"><li class=\"fusion-li-item\"><span style=\"height:22.1px;width:22.1px;margin-right:9.1px;\" class=\"icon-wrapper circle-no\"><i class=\"fusion-li-icon fa fa-arrow-left\" style=\"color:teal;\" aria-hidden=\"true\"></i></span><div class=\"fusion-li-item-content\" style=\"margin-left:31.2px;\">\n<p><a href=\"./blog/\">Back to Kinapse blog</a></p>\n</div></li></ul><div class=\"fusion-clearfix\"></div></div></div></div></div><div class=\"fusion-fullwidth fullwidth-box fusion-builder-row-2 nonhundred-percent-fullwidth non-hundred-percent-height-scrolling\" style=\"background-color: rgba(255,255,255,0);background-position: center center;background-repeat: no-repeat;padding-top:0px;padding-right:0px;padding-bottom:0px;padding-left:0px;margin-bottom: 0px;margin-top: 0px;border-width: 0px 0px 0px 0px;border-color:#eae9e9;border-style:solid;\" ><div class=\"fusion-builder-row fusion-row\"><div class=\"fusion-layout-column fusion_builder_column fusion-builder-column-1 fusion_builder_column_1_1 1_1 fusion-one-full fusion-column-first fusion-column-last\" style=\"margin-top:0px;margin-bottom:30px;\"><div class=\"fusion-column-wrapper fusion-flex-column-wrapper-legacy\" style=\"background-position:left top;background-repeat:no-repeat;-webkit-background-size:cover;-moz-background-size:cover;-o-background-size:cover;background-size:cover;background-color:#253745;padding: 3% 0px 0px 0px;\"><style type=\"text/css\"></style><div class=\"fusion-title title fusion-title-1 fusion-sep-none fusion-title-text fusion-title-size-two\" style=\"margin-top:20px;margin-right:0px;margin-bottom:15px;margin-left:0px;\"><h2 class=\"title-heading-left\" style=\"margin:0;\"><h1 style=\"text-align: center;\"><span style=\"color: #ffffff;\">The Regulatory Times</span></h1></h2></div><div class=\"fusion-text fusion-text-1\"><h6 style=\"text-align: center;\"><span style=\"color: #ffffff;\">May\u00a02019</span></h6>\n</div><div class=\"fusion-text fusion-text-2\"><p style=\"text-align: center;\"><span style=\"color: #f2f2f2;\">Your monthly round-up of international Life Sciences regulatory news from the past month</span></p>\n</div><div class=\"fusion-clearfix\"></div></div></div><div class=\"fusion-layout-column fusion_builder_column fusion-builder-column-2 fusion_builder_column_1_1 1_1 fusion-one-full fusion-column-first fusion-column-last\" style=\"margin-top:0px;margin-bottom:30px;\"><div class=\"fusion-column-wrapper fusion-flex-column-wrapper-legacy\" style=\"background-position:left top;background-repeat:no-repeat;-webkit-background-size:cover;-moz-background-size:cover;-o-background-size:cover;background-size:cover;background-color:teal;padding: 0.5% 0px 0px 0px;\"><style type=\"text/css\"></style><div class=\"fusion-title title fusion-title-2 fusion-sep-none fusion-title-text fusion-title-size-two\" style=\"margin-top:20px;margin-right:0px;margin-bottom:15px;margin-left:0px;\"><h2 class=\"title-heading-left\" style=\"margin:0;\"><p style=\"text-align: center;\"><span style=\"color: #ffffff;\">US</span></p></h2></div><div class=\"fusion-clearfix\"></div></div></div><div class=\"fusion-layout-column fusion_builder_column fusion-builder-column-3 fusion_builder_column_1_1 1_1 fusion-one-full fusion-column-first fusion-column-last\" style=\"margin-top:0px;margin-bottom:30px;\"><div class=\"fusion-column-wrapper fusion-flex-column-wrapper-legacy\" style=\"background-position:left top;background-repeat:no-repeat;-webkit-background-size:cover;-moz-background-size:cover;-o-background-size:cover;background-size:cover;background-color:#f2f2f2;padding: 0px 0px 0px 0px;\"><div class=\"fusion-builder-row fusion-builder-row-inner fusion-row\"><div class=\"fusion-layout-column fusion_builder_column_inner fusion-builder-nested-column-0 fusion_builder_column_inner_1_1 1_1 fusion-one-full fusion-column-first fusion-column-last\" style=\"margin-top:0px;margin-bottom:30px;\"><div class=\"fusion-column-wrapper fusion-flex-column-wrapper-legacy\" style=\"background-position:left top;background-repeat:no-repeat;-webkit-background-size:cover;-moz-background-size:cover;-o-background-size:cover;background-size:cover;padding: 4% 2% 0px 2%;\"><div class=\"fusion-text fusion-text-3\"><p><span style=\"color: #1d866c;\"><strong>Determining Whether To Submit an Abbreviated New Drug Application or a 505(b)(2) Application Guidance for Industry</strong></span></p>\n<p>This foundational guidance is intended to assist applicants in determining which abbreviated approval pathway under the Federal Food, Drug, and Cosmetic Act (FD&amp;C) is appropriate for the submission of a marketing application to the FDA. Many potential drug product developers are not familiar with the different abbreviated approval pathways for drug products under this act \u2014 the abbreviated approval pathways described in section 505(j) and 505(b)(2) of the FD&amp;C Act (21 U.S.C. 355(j) and 21 U.S.C. 355(b)(2), respectively) \u2014 or the types of data and information that are permitted to support approval under those pathways.</p>\n<p>This guidance focuses on those applications that can be submitted as ANDAs under section 505(j) of the FD&amp;C Act, petitioned ANDAs under section 505(j)(2)(C) of the FD&amp;C Act, or NDAs pursuant to section 505(b)(2) of the FD&amp;C Act. This guidance does not discuss standalone NDAs.</p>\n<p>Submission through the appropriate Abbreviated approval pathway with Regulatory Considerations for ANDAs and 505(b)(2) Applications (Duplicates, Petitioned ANDAs, Bundling) and Scientific Considerations for ANDAs and 505(b)(2) Applications (Type of Studies, Data and Information Submitted in ANDAs, Active Ingredient Sameness Evaluation, Intentional Differences Between the Proposed Drug Product and the RLD and Other Differences) is discussed in the guidance.</p>\n<p>Additionally the procedure for requesting assistance from FDA is also discussed in the guidance.</p>\n<p><em>For details please refer to the PDF provided below:</em></p>\n<p><a href=\"https://www.fda.gov/media/124848/download\"><span style=\"color: teal;\"><strong>PDF Download</strong></span></a></p>\n</div><div class=\"fusion-clearfix\"></div></div></div></div><div class=\"fusion-sep-clear\"></div><div class=\"fusion-separator fusion-full-width-sep\" style=\"margin-left: auto;margin-right: auto;width:100%;max-width:100%;\"><div class=\"fusion-separator-border sep-single sep-solid\" style=\"border-color:#ffffff;border-top-width:30px;\"></div></div><div class=\"fusion-sep-clear\"></div><div class=\"fusion-clearfix\"></div></div></div><div class=\"fusion-layout-column fusion_builder_column fusion-builder-column-4 fusion_builder_column_1_1 1_1 fusion-one-full fusion-column-first fusion-column-last\" style=\"margin-top:0px;margin-bottom:30px;\"><div class=\"fusion-column-wrapper fusion-flex-column-wrapper-legacy\" style=\"background-position:left top;background-repeat:no-repeat;-webkit-background-size:cover;-moz-background-size:cover;-o-background-size:cover;background-size:cover;background-color:teal;padding: 0.5% 0px 0px 0px;\"><style type=\"text/css\"></style><div class=\"fusion-title title fusion-title-3 fusion-sep-none fusion-title-text fusion-title-size-two\" style=\"margin-top:20px;margin-right:0px;margin-bottom:15px;margin-left:0px;\"><h2 class=\"title-heading-left\" style=\"margin:0;\"><p style=\"text-align: center;\"><span style=\"color: #ffffff;\">EU</span></p></h2></div><div class=\"fusion-clearfix\"></div></div></div><div class=\"fusion-layout-column fusion_builder_column fusion-builder-column-5 fusion_builder_column_1_1 1_1 fusion-one-full fusion-column-first fusion-column-last\" style=\"margin-top:0px;margin-bottom:30px;\"><div class=\"fusion-column-wrapper fusion-flex-column-wrapper-legacy\" style=\"background-position:left top;background-repeat:no-repeat;-webkit-background-size:cover;-moz-background-size:cover;-o-background-size:cover;background-size:cover;background-color:#f2f2f2;padding: 0px 0px 0px 0px;\"><div class=\"fusion-builder-row fusion-builder-row-inner fusion-row\"><div class=\"fusion-layout-column fusion_builder_column_inner fusion-builder-nested-column-1 fusion_builder_column_inner_1_1 1_1 fusion-one-full fusion-column-first fusion-column-last\" style=\"margin-top:0px;margin-bottom:30px;\"><div class=\"fusion-column-wrapper fusion-flex-column-wrapper-legacy\" style=\"background-position:left top;background-repeat:no-repeat;-webkit-background-size:cover;-moz-background-size:cover;-o-background-size:cover;background-size:cover;padding: 4% 2% 0px 2%;\"><div class=\"fusion-text fusion-text-4\"><p><span style=\"color: #1d866c;\"><strong>Regulations on Common Regulatory Approaches for Allergen Products</strong></span></p>\n<p>The document is intended to provide principles and guidance for the regulation of medicinal allergen products with the aim to facilitate harmonisation throughout the EU. In this regard, applicable regulatory approaches for different classes of allergen products are discussed. This includes products of biological origin (allergen extracts derived from natural source materials) used for allergen immunotherapy (AIT), or for in vivo diagnosis of Type I (IgE)-mediated allergic diseases (e.g. skin prick test and nasal provocation test), and products intended for the diagnosis of Type IV cell-mediated allergies (e.g. patch test based on haptens).</p>\n<p>The recommendations developed in this document generally apply to all allergen medicinal products as defined by Directive 2001/83/EC. As such, only medicinal products for human use intended to be placed on the market in Member States that are either prepared industrially or manufactured by a method involving an industrial process are concerned. It applies to all such products, including those for which a new MA is intended, or those that are already marketed with or without a MA.</p>\n<p><em>Follow the link for full details:</em></p>\n<p><a href=\"https://www.hma.eu/fileadmin/dateien/Human_Medicines/CMD_h_/procedural_guidance/01_General_Info/CMDh_399_2019_2019_04_Public_consultation_-_AllergenRegulatoryGuideline_Draft.docx\"><strong>HMA Website</strong></a></p>\n</div><div class=\"fusion-clearfix\"></div></div></div></div><div class=\"fusion-clearfix\"></div></div></div><div class=\"fusion-layout-column fusion_builder_column fusion-builder-column-6 fusion_builder_column_1_2 1_2 fusion-one-half fusion-column-first\" style=\"width:50%;width:calc(50% - ( ( 4% ) * 0.5 ) );margin-right: 4%;margin-top:0px;margin-bottom:30px;\"><div class=\"fusion-column-wrapper fusion-flex-column-wrapper-legacy\" style=\"background-position:left top;background-repeat:no-repeat;-webkit-background-size:cover;-moz-background-size:cover;-o-background-size:cover;background-size:cover;background-color:#f2f2f2;padding: 0px 0px 0px 0px;\"><div class=\"fusion-builder-row fusion-builder-row-inner fusion-row\"><div class=\"fusion-layout-column fusion_builder_column_inner fusion-builder-nested-column-2 fusion_builder_column_inner_1_1 1_1 fusion-one-full fusion-column-first fusion-column-last\" style=\"margin-top:0px;margin-bottom:30px;\"><div class=\"fusion-column-wrapper fusion-flex-column-wrapper-legacy\" style=\"background-position:left top;background-repeat:no-repeat;-webkit-background-size:cover;-moz-background-size:cover;-o-background-size:cover;background-size:cover;padding: 4% 2% 0px 2%;\"><div class=\"fusion-text fusion-text-5\"><p><span style=\"color: #1d866c;\"><strong>Two Additional Countries to Benefit from EU-US Mutual Recognition Agreement for Inspections</strong></span></p>\n<p>On April 2019, the FDA confirmed the competence of two additional European Union Member States to carry out GMP inspections at a level equivalent to the United States (US). Bulgaria and Cyprus have been incorporated into the mutual recognition agreement between the EU and the US on 29 April 2019. The agreement mutually recognises inspections of manufacturing sites for human medicines conducted in the different territories and this means that the FDA will now rely on a total of 24 Member States whose inspection results can replace their own inspections</p>\n<p><em>For details, please below to the link below</em><em>:</em></p>\n<p><a href=\"https://www.ema.europa.eu/en/news/two-additional-countries-benefit-eu-us-mutual-recognition-agreement-inspections-0\"><strong>EMA Website</strong></a></p>\n</div><div class=\"fusion-clearfix\"></div></div></div></div><div class=\"fusion-clearfix\"></div></div></div><div class=\"fusion-layout-column fusion_builder_column fusion-builder-column-7 fusion_builder_column_1_2 1_2 fusion-one-half fusion-column-last\" style=\"width:50%;width:calc(50% - ( ( 4% ) * 0.5 ) );margin-top:0px;margin-bottom:30px;\"><div class=\"fusion-column-wrapper fusion-flex-column-wrapper-legacy\" style=\"background-position:left top;background-repeat:no-repeat;-webkit-background-size:cover;-moz-background-size:cover;-o-background-size:cover;background-size:cover;background-color:#f2f2f2;padding: 0px 0px 0px 0px;\"><div class=\"fusion-builder-row fusion-builder-row-inner fusion-row\"><div class=\"fusion-layout-column fusion_builder_column_inner fusion-builder-nested-column-3 fusion_builder_column_inner_1_1 1_1 fusion-one-full fusion-column-first fusion-column-last\" style=\"margin-top:0px;margin-bottom:30px;\"><div class=\"fusion-column-wrapper fusion-flex-column-wrapper-legacy\" style=\"background-position:left top;background-repeat:no-repeat;-webkit-background-size:cover;-moz-background-size:cover;-o-background-size:cover;background-size:cover;padding: 4% 2% 0px 2%;\"><div class=\"fusion-text fusion-text-6\"><p><span style=\"color: #1d866c;\"><strong>European Commission Confirms Quality of South Korean Active Substances</strong></span></p>\n<p>The European Commission confirmed that the quality of active substances produced in the Republic of Korea are in line with EU standards. South Korea joins Australia, Brazil, Israel, Japan, Switzerland and the US as countries outside of the EU that have been established as manufacturing active substances in an EU-equivalent regulatory system with sufficient rules for manufacturing practices.</p>\n<p><em>For more details, please refer to the PDF below</em><em>:</em></p>\n<p><a href=\"https://ec.europa.eu/health/sites/health/files/files/gmp/2019_repkorea_en.pdf\"><strong>PDF Download</strong></a></p>\n</div><div class=\"fusion-clearfix\"></div></div></div></div><div class=\"fusion-clearfix\"></div></div></div><div class=\"fusion-layout-column fusion_builder_column fusion-builder-column-8 fusion_builder_column_1_1 1_1 fusion-one-full fusion-column-first fusion-column-last\" style=\"margin-top:0px;margin-bottom:30px;\"><div class=\"fusion-column-wrapper fusion-flex-column-wrapper-legacy\" style=\"background-position:left top;background-repeat:no-repeat;-webkit-background-size:cover;-moz-background-size:cover;-o-background-size:cover;background-size:cover;background-color:teal;padding: 0.5% 0px 0px 0px;\"><style type=\"text/css\"></style><div class=\"fusion-title title fusion-title-4 fusion-sep-none fusion-title-text fusion-title-size-two\" style=\"margin-top:20px;margin-right:0px;margin-bottom:15px;margin-left:0px;\"><h2 class=\"title-heading-left\" style=\"margin:0;\"><p style=\"text-align: center;\"><span style=\"color: #ffffff;\">Emerging Markets</span></p></h2></div><div class=\"fusion-clearfix\"></div></div></div><div class=\"fusion-layout-column fusion_builder_column fusion-builder-column-9 fusion_builder_column_1_1 1_1 fusion-one-full fusion-column-first fusion-column-last\" style=\"margin-top:0px;margin-bottom:30px;\"><div class=\"fusion-column-wrapper fusion-flex-column-wrapper-legacy\" style=\"background-position:left top;background-repeat:no-repeat;-webkit-background-size:cover;-moz-background-size:cover;-o-background-size:cover;background-size:cover;background-color:#ffffff;padding: 0.5% 0px 0px 0px;\"><style type=\"text/css\"></style><div class=\"fusion-title title fusion-title-5 fusion-sep-none fusion-title-text fusion-title-size-two\" style=\"margin-top:20px;margin-right:0px;margin-bottom:15px;margin-left:0px;\"><h2 class=\"title-heading-left\" style=\"margin:0;\"><p style=\"text-align: center;\"><span style=\"color: teal;\">Singapore</span></p></h2></div><div class=\"fusion-clearfix\"></div></div></div><div class=\"fusion-layout-column fusion_builder_column fusion-builder-column-10 fusion_builder_column_1_1 1_1 fusion-one-full fusion-column-first fusion-column-last\" style=\"margin-top:0px;margin-bottom:30px;\"><div class=\"fusion-column-wrapper fusion-flex-column-wrapper-legacy\" style=\"background-position:left top;background-repeat:no-repeat;-webkit-background-size:cover;-moz-background-size:cover;-o-background-size:cover;background-size:cover;background-color:#f2f2f2;padding: 0px 0px 0px 0px;\"><div class=\"fusion-builder-row fusion-builder-row-inner fusion-row\"><div class=\"fusion-layout-column fusion_builder_column_inner fusion-builder-nested-column-4 fusion_builder_column_inner_1_1 1_1 fusion-one-full fusion-column-first fusion-column-last\" style=\"margin-top:0px;margin-bottom:30px;\"><div class=\"fusion-column-wrapper fusion-flex-column-wrapper-legacy\" style=\"background-position:left top;background-repeat:no-repeat;-webkit-background-size:cover;-moz-background-size:cover;-o-background-size:cover;background-size:cover;padding: 4% 2% 0px 2%;\"><div class=\"fusion-text fusion-text-7\"><p><span style=\"color: #1d866c;\"><strong>Regulatory Fee Revision for Health Products (effective 2nd April 2019)</strong></span></p>\n<p>The HSA has introduced the fee revision for health products which has been implemented from 2 April 2019. This document is important for industry stakeholders which states that all renewal and retention system notification emails sent before 2 April 2019 will reflect the old fees instead of the current fees payable. The applicable fees will be processed accordingly.</p>\n<p><em>Follow the link below for full details:</em></p>\n<p><a href=\"https://cdsco.gov.in/opencms/export/sites/CDSCO_WEB/Pdf-documents/NewDrugs_CTRules_2019.pdf\"><strong>HSA Website</strong></a></p>\n</div><div class=\"fusion-clearfix\"></div></div></div></div><div class=\"fusion-clearfix\"></div></div></div></div></div><div class=\"fusion-fullwidth fullwidth-box fusion-builder-row-3 nonhundred-percent-fullwidth non-hundred-percent-height-scrolling\" style=\"background-color: rgba(255,255,255,0);background-position: center center;background-repeat: no-repeat;padding-top:3%;padding-right:0px;padding-bottom:3%;padding-left:0px;margin-bottom: 0px;margin-top: 0px;border-width: 0px 0px 0px 0px;border-color:#eae9e9;border-style:solid;\" ><div class=\"fusion-builder-row fusion-row\"><div class=\"fusion-layout-column fusion_builder_column fusion-builder-column-11 fusion_builder_column_1_6 1_6 fusion-one-sixth fusion-column-first\" style=\"width:16.666666666667%;width:calc(16.666666666667% - ( ( 4% + 4% ) * 0.16666666666667 ) );margin-right: 4%;margin-top:0px;margin-bottom:30px;\"><div class=\"fusion-column-wrapper fusion-flex-column-wrapper-legacy\" style=\"background-position:left top;background-repeat:no-repeat;-webkit-background-size:cover;-moz-background-size:cover;-o-background-size:cover;background-size:cover;padding: 0px 0px 0px 0px;\"><div class=\"fusion-clearfix\"></div></div></div><div class=\"fusion-layout-column fusion_builder_column fusion-builder-column-12 fusion_builder_column_2_3 2_3 fusion-two-third\" style=\"width:66.666666666667%;width:calc(66.666666666667% - ( ( 4% + 4% ) * 0.66666666666667 ) );margin-right: 4%;margin-top:0px;margin-bottom:30px;\"><div class=\"fusion-column-wrapper fusion-flex-column-wrapper-legacy\" style=\"background-position:left top;background-repeat:no-repeat;-webkit-background-size:cover;-moz-background-size:cover;-o-background-size:cover;background-size:cover;padding: 0px 0px 0px 0px;\"><style type=\"text/css\"></style><div class=\"fusion-title title fusion-title-6 fusion-sep-none fusion-title-text fusion-title-size-one\" style=\"margin-top:0px;margin-right:0px;margin-bottom:10px;margin-left:0px;\"><h1 class=\"title-heading-left\" style=\"margin:0;\"><h5><span style=\"color: #000000;\">Share this page:</span></h5></h1></div><div class=\"fusion-widget-area fusion-widget-area-1 fusion-content-widget-area\"><style type=\"text/css\">.fusion-widget-area-1 {padding:0px 0px 0px 0px;}.fusion-widget-area-1 .widget h4 {color:#333c4e;}.fusion-widget-area-1 .widget .heading h4 {color:#333c4e;}.fusion-widget-area-1 .widget h4 {font-size:18px;}.fusion-widget-area-1 .widget .heading h4 {font-size:18px;}</style><div class='the_champ_sharing_container the_champ_horizontal_sharing' data-super-socializer-href=\"./wp-json/wp/v2/posts/11409\"><div id=\"thechamphorizontalsharing-2\" class=\"widget widget_thechamphorizontalsharing\"><div class=\"the_champ_sharing_ul\"><a class=\"the_champ_button_linkedin\" href=\"https://www.linkedin.com/shareArticle?mini=true&url=https%3A%2F%2F#%2Fwp-json%2Fwp%2Fv2%2Fposts%2F11409&title=Kinapse%20website%20-%20Kinapse%20website\" title=\"Linkedin\" rel=\"nofollow noopener\" target=\"_blank\" style=\"font-size:24px!important;box-shadow:none;display:inline-block;vertical-align:middle\"><span class=\"the_champ_svg the_champ_s__default the_champ_s_linkedin\" style=\"background-color:#0077b5;width:35px;height:35px;border-radius:999px;display:inline-block;opacity:1;float:left;font-size:24px;box-shadow:none;display:inline-block;font-size:16px;padding:0 4px;vertical-align:middle;background-repeat:repeat;overflow:hidden;padding:0;cursor:pointer;box-sizing:content-box\"><svg style=\"display:block;border-radius:999px;\" focusable=\"false\" aria-hidden=\"true\" xmlns=\"http://www.w3.org/2000/svg\" width=\"100%\" height=\"100%\" viewBox=\"0 0 32 32\"><path d=\"M6.227 12.61h4.19v13.48h-4.19V12.61zm2.095-6.7a2.43 2.43 0 0 1 0 4.86c-1.344 0-2.428-1.09-2.428-2.43s1.084-2.43 2.428-2.43m4.72 6.7h4.02v1.84h.058c.56-1.058 1.927-2.176 3.965-2.176 4.238 0 5.02 2.792 5.02 6.42v7.395h-4.183v-6.56c0-1.564-.03-3.574-2.178-3.574-2.18 0-2.514 1.7-2.514 3.46v6.668h-4.187V12.61z\" fill=\"#FFF\"></path></svg></span></a><a class=\"the_champ_button_twitter\" href=\"https://twitter.com/intent/tweet?text=The%20Regulatory%20Times%20-%20May%202019&url=https%3A%2F%2F#%2Fwp-json%2Fwp%2Fv2%2Fposts%2F11409\" title=\"Twitter\" rel=\"nofollow noopener\" target=\"_blank\" style=\"font-size:24px!important;box-shadow:none;display:inline-block;vertical-align:middle\"><span class=\"the_champ_svg the_champ_s__default the_champ_s_twitter\" style=\"background-color:#55acee;width:35px;height:35px;border-radius:999px;display:inline-block;opacity:1;float:left;font-size:24px;box-shadow:none;display:inline-block;font-size:16px;padding:0 4px;vertical-align:middle;background-repeat:repeat;overflow:hidden;padding:0;cursor:pointer;box-sizing:content-box\"><svg style=\"display:block;border-radius:999px;\" focusable=\"false\" aria-hidden=\"true\" xmlns=\"http://www.w3.org/2000/svg\" width=\"100%\" height=\"100%\" viewBox=\"-4 -4 39 39\"><path d=\"M28 8.557a9.913 9.913 0 0 1-2.828.775 4.93 4.93 0 0 0 2.166-2.725 9.738 9.738 0 0 1-3.13 1.194 4.92 4.92 0 0 0-3.593-1.55 4.924 4.924 0 0 0-4.794 6.049c-4.09-.21-7.72-2.17-10.15-5.15a4.942 4.942 0 0 0-.665 2.477c0 1.71.87 3.214 2.19 4.1a4.968 4.968 0 0 1-2.23-.616v.06c0 2.39 1.7 4.38 3.952 4.83-.414.115-.85.174-1.297.174-.318 0-.626-.03-.928-.086a4.935 4.935 0 0 0 4.6 3.42 9.893 9.893 0 0 1-6.114 2.107c-.398 0-.79-.023-1.175-.068a13.953 13.953 0 0 0 7.55 2.213c9.056 0 14.01-7.507 14.01-14.013 0-.213-.005-.426-.015-.637.96-.695 1.795-1.56 2.455-2.55z\" fill=\"#FFF\"></path></svg></span></a><a class=\"the_champ_facebook\" href=\"https://www.facebook.com/sharer/sharer.php?u=https%3A%2F%2F#%2Fwp-json%2Fwp%2Fv2%2Fposts%2F11409\" title=\"Facebook\" rel=\"nofollow noopener\" target=\"_blank\" style=\"font-size:24px!important;box-shadow:none;display:inline-block;vertical-align:middle\"><span class=\"the_champ_svg\" style=\"background-color:#3c589a;width:35px;height:35px;border-radius:999px;display:inline-block;opacity:1;float:left;font-size:24px;box-shadow:none;display:inline-block;font-size:16px;padding:0 4px;vertical-align:middle;background-repeat:repeat;overflow:hidden;padding:0;cursor:pointer;box-sizing:content-box\"><svg style=\"display:block;border-radius:999px;\" focusable=\"false\" aria-hidden=\"true\" xmlns=\"http://www.w3.org/2000/svg\" width=\"100%\" height=\"100%\" viewBox=\"-5 -5 42 42\"><path d=\"M17.78 27.5V17.008h3.522l.527-4.09h-4.05v-2.61c0-1.182.33-1.99 2.023-1.99h2.166V4.66c-.375-.05-1.66-.16-3.155-.16-3.123 0-5.26 1.905-5.26 5.405v3.016h-3.53v4.09h3.53V27.5h4.223z\" fill=\"#FFF\"></path></svg></span></a><a class=\"the_champ_more\" title=\"More\" rel=\"nofollow noopener\" style=\"font-size:24px!important;border:0;box-shadow:none;display:inline-block!important;font-size:16px;padding:0 4px;vertical-align: middle;display:inline;\" href=\"./wp-json/wp/v2/posts/11409\" onclick=\"event.preventDefault()\"><span class=\"the_champ_svg\" style=\"background-color:#ee8e2d;width:35px;height:35px;border-radius:999px;display:inline-block!important;opacity:1;float:left;font-size:32px!important;box-shadow:none;display:inline-block;font-size:16px;padding:0 4px;vertical-align:middle;display:inline;background-repeat:repeat;overflow:hidden;padding:0;cursor:pointer;box-sizing:content-box;\" onclick=\"theChampMoreSharingPopup(this, './wp-json/wp/v2/posts/11409', 'Kinapse%20website%20-%20Kinapse%20website', 'The%20Regulatory%20Times%20-%20May%202019' )\"><svg xmlns=\"http://www.w3.org/2000/svg\" xmlns:xlink=\"http://www.w3.org/1999/xlink\" viewBox=\"-.3 0 32 32\" version=\"1.1\" width=\"100%\" height=\"100%\" style=\"display:block;border-radius:999px;\" xml:space=\"preserve\"><g><path fill=\"#FFF\" d=\"M18 14V8h-4v6H8v4h6v6h4v-6h6v-4h-6z\" fill-rule=\"evenodd\"></path></g></svg></span></a></div></div></div><div class=\"fusion-additional-widget-content\"></div></div><div class=\"fusion-clearfix\"></div></div></div><div class=\"fusion-layout-column fusion_builder_column fusion-builder-column-13 fusion_builder_column_1_6 1_6 fusion-one-sixth fusion-column-last\" style=\"width:16.666666666667%;width:calc(16.666666666667% - ( ( 4% + 4% ) * 0.16666666666667 ) );margin-top:0px;margin-bottom:0px;\"><div class=\"fusion-column-wrapper fusion-flex-column-wrapper-legacy\" style=\"background-position:left top;background-repeat:no-repeat;-webkit-background-size:cover;-moz-background-size:cover;-o-background-size:cover;background-size:cover;padding: 0px 0px 0px 0px;\"><div class=\"fusion-clearfix\"></div></div></div></div></div></p>\n",
    "protected": false
  },
  "excerpt": {
    "rendered": "<p>Your monthly round-up of international Life Sciences regulatory news from the past month. Follow the link to read April&#8217;s edition from Kinapse.</p>\n",
    "protected": false
  },
  "author": 14,
  "featured_media": 11412,
  "comment_status": "open",
  "ping_status": "open",
  "sticky": false,
  "template": "",
  "format": "standard",
  "meta": { "_mi_skip_tracking": false },
  "categories": [35],
  "tags": [],
  "acf": [],
  "yoast_head": "<!-- This site is optimized with the Yoast SEO plugin v19.9 - https://yoast.com/wordpress/plugins/seo/ -->\n<title>Kinapse Blog | The Regulatory Times - May 2019</title>\n<meta name=\"description\" content=\"Your monthly round-up of international Life Sciences regulatory news from the past month. Follow the link to read May&#039;s edition from Kinapse.\" />\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" />\n<link rel=\"canonical\" href=\"./blog/regulatory-times-may-2019/\" />\n<meta property=\"og:locale\" content=\"en_GB\" />\n<meta property=\"og:type\" content=\"article\" />\n<meta property=\"og:title\" content=\"The Regulatory Times - May 2019\" />\n<meta property=\"og:description\" content=\"Your monthly round-up of international Life Sciences regulatory news from the past month. Follow the link to read May&#039;s edition from Kinapse.\" />\n<meta property=\"og:url\" content=\"./blog/regulatory-times-may-2019/\" />\n<meta property=\"og:site_name\" content=\"Kinapse website\" />\n<meta property=\"article:published_time\" content=\"2019-07-03T12:45:08+00:00\" />\n<meta property=\"og:image\" content=\"./wp-content/uploads/2019/07/The-Regulatory-Times-May-2019-e1562151667189.jpg\" />\n\t<meta property=\"og:image:width\" content=\"1200\" />\n\t<meta property=\"og:image:height\" content=\"800\" />\n\t<meta property=\"og:image:type\" content=\"image/jpeg\" />\n<meta name=\"author\" content=\"Ed Ricketts\" />\n<meta name=\"twitter:card\" content=\"summary_large_image\" />\n<meta name=\"twitter:title\" content=\"The Regulatory Times - May 2019\" />\n<meta name=\"twitter:description\" content=\"Your monthly round-up of international Life Sciences regulatory news from the past month. Follow the link to read May&#039;s edition from Kinapse.\" />\n<meta name=\"twitter:image\" content=\"./wp-content/uploads/2019/07/The-Regulatory-Times-May-2019-e1562151667189.jpg\" />\n<meta name=\"twitter:label1\" content=\"Written by\" />\n\t<meta name=\"twitter:data1\" content=\"Ed Ricketts\" />\n\t<meta name=\"twitter:label2\" content=\"Estimated reading time\" />\n\t<meta name=\"twitter:data2\" content=\"14 minutes\" />\n<script type=\"application/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https://schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"./blog/regulatory-times-may-2019/\",\"url\":\"./blog/regulatory-times-may-2019/\",\"name\":\"Kinapse Blog | The Regulatory Times - May 2019\",\"isPartOf\":{\"@id\":\"./#website\"},\"datePublished\":\"2019-07-03T12:45:08+00:00\",\"dateModified\":\"2019-07-03T12:45:08+00:00\",\"author\":{\"@id\":\"./#/schema/person/f746367cd3256d31f7d02a01ad60b3b6\"},\"description\":\"Your monthly round-up of international Life Sciences regulatory news from the past month. Follow the link to read May's edition from Kinapse.\",\"breadcrumb\":{\"@id\":\"./blog/regulatory-times-may-2019/#breadcrumb\"},\"inLanguage\":\"en-GB\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"./blog/regulatory-times-may-2019/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"./blog/regulatory-times-may-2019/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"./\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"The Regulatory Times &#8211; May 2019\"}]},{\"@type\":\"WebSite\",\"@id\":\"./#website\",\"url\":\"./\",\"name\":\"Kinapse website\",\"description\":\"Kinapse website\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"./?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"en-GB\"},{\"@type\":\"Person\",\"@id\":\"./#/schema/person/f746367cd3256d31f7d02a01ad60b3b6\",\"name\":\"Ed Ricketts\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-GB\",\"@id\":\"./#/schema/person/image/\",\"url\":\"https://secure.gravatar.com/avatar/5e1d661561924b8b0b03c2463d26825d?s=96&d=mm&r=g\",\"contentUrl\":\"https://secure.gravatar.com/avatar/5e1d661561924b8b0b03c2463d26825d?s=96&d=mm&r=g\",\"caption\":\"Ed Ricketts\"},\"sameAs\":[\"http://#\"],\"url\":\"./author/ed-ricketts/\"}]}</script>\n<!-- / Yoast SEO plugin. -->",
  "yoast_head_json": {
    "title": "Kinapse Blog | The Regulatory Times - May 2019",
    "description": "Your monthly round-up of international Life Sciences regulatory news from the past month. Follow the link to read May's edition from Kinapse.",
    "robots": {
      "index": "index",
      "follow": "follow",
      "max-snippet": "max-snippet:-1",
      "max-image-preview": "max-image-preview:large",
      "max-video-preview": "max-video-preview:-1"
    },
    "canonical": "./blog/regulatory-times-may-2019/",
    "og_locale": "en_GB",
    "og_type": "article",
    "og_title": "The Regulatory Times - May 2019",
    "og_description": "Your monthly round-up of international Life Sciences regulatory news from the past month. Follow the link to read May's edition from Kinapse.",
    "og_url": "./blog/regulatory-times-may-2019/",
    "og_site_name": "Kinapse website",
    "article_published_time": "2019-07-03T12:45:08+00:00",
    "og_image": [
      {
        "width": 1200,
        "height": 800,
        "url": "./wp-content/uploads/2019/07/The-Regulatory-Times-May-2019-e1562151667189.jpg",
        "type": "image/jpeg"
      }
    ],
    "author": "Ed Ricketts",
    "twitter_card": "summary_large_image",
    "twitter_title": "The Regulatory Times - May 2019",
    "twitter_description": "Your monthly round-up of international Life Sciences regulatory news from the past month. Follow the link to read May's edition from Kinapse.",
    "twitter_image": "./wp-content/uploads/2019/07/The-Regulatory-Times-May-2019-e1562151667189.jpg",
    "twitter_misc": {
      "Written by": "Ed Ricketts",
      "Estimated reading time": "14 minutes"
    },
    "schema": {
      "@context": "https://schema.org",
      "@graph": [
        {
          "@type": "WebPage",
          "@id": "./blog/regulatory-times-may-2019/",
          "url": "./blog/regulatory-times-may-2019/",
          "name": "Kinapse Blog | The Regulatory Times - May 2019",
          "isPartOf": { "@id": "./#website" },
          "datePublished": "2019-07-03T12:45:08+00:00",
          "dateModified": "2019-07-03T12:45:08+00:00",
          "author": {
            "@id": "./#/schema/person/f746367cd3256d31f7d02a01ad60b3b6"
          },
          "description": "Your monthly round-up of international Life Sciences regulatory news from the past month. Follow the link to read May's edition from Kinapse.",
          "breadcrumb": {
            "@id": "./blog/regulatory-times-may-2019/#breadcrumb"
          },
          "inLanguage": "en-GB",
          "potentialAction": [
            {
              "@type": "ReadAction",
              "target": ["./blog/regulatory-times-may-2019/"]
            }
          ]
        },
        {
          "@type": "BreadcrumbList",
          "@id": "./blog/regulatory-times-may-2019/#breadcrumb",
          "itemListElement": [
            {
              "@type": "ListItem",
              "position": 1,
              "name": "Home",
              "item": "./"
            },
            {
              "@type": "ListItem",
              "position": 2,
              "name": "The Regulatory Times &#8211; May 2019"
            }
          ]
        },
        {
          "@type": "WebSite",
          "@id": "./#website",
          "url": "./",
          "name": "Kinapse website",
          "description": "Kinapse website",
          "potentialAction": [
            {
              "@type": "SearchAction",
              "target": {
                "@type": "EntryPoint",
                "urlTemplate": "./?s={search_term_string}"
              },
              "query-input": "required name=search_term_string"
            }
          ],
          "inLanguage": "en-GB"
        },
        {
          "@type": "Person",
          "@id": "./#/schema/person/f746367cd3256d31f7d02a01ad60b3b6",
          "name": "Ed Ricketts",
          "image": {
            "@type": "ImageObject",
            "inLanguage": "en-GB",
            "@id": "./#/schema/person/image/",
            "url": "https://secure.gravatar.com/avatar/5e1d661561924b8b0b03c2463d26825d?s=96&d=mm&r=g",
            "contentUrl": "https://secure.gravatar.com/avatar/5e1d661561924b8b0b03c2463d26825d?s=96&d=mm&r=g",
            "caption": "Ed Ricketts"
          },
          "sameAs": ["http://#"],
          "url": "./author/ed-ricketts/"
        }
      ]
    }
  },
  "_links": {
    "self": [{ "href": "./wp-json/wp/v2/posts/11409" }],
    "collection": [{ "href": "./wp-json/wp/v2/posts" }],
    "about": [{ "href": "./wp-json/wp/v2/types/post" }],
    "author": [
      { "embeddable": true, "href": "./wp-json/wp/v2/users/14" }
    ],
    "replies": [
      {
        "embeddable": true,
        "href": "./wp-json/wp/v2/comments?post=11409"
      }
    ],
    "version-history": [
      { "count": 7, "href": "./wp-json/wp/v2/posts/11409/revisions" }
    ],
    "predecessor-version": [
      {
        "id": 11426,
        "href": "./wp-json/wp/v2/posts/11409/revisions/11426"
      }
    ],
    "wp:featuredmedia": [
      { "embeddable": true, "href": "./wp-json/wp/v2/media/11412" }
    ],
    "wp:attachment": [{ "href": "./wp-json/wp/v2/media?parent=11409" }],
    "wp:term": [
      {
        "taxonomy": "category",
        "embeddable": true,
        "href": "./wp-json/wp/v2/categories?post=11409"
      },
      {
        "taxonomy": "post_tag",
        "embeddable": true,
        "href": "./wp-json/wp/v2/tags?post=11409"
      }
    ],
    "curies": [
      { "name": "wp", "href": "https://api.w.org/{rel}", "templated": true }
    ]
  }
}
